8-K
filed May 6, 2025, 7:59 PM ET
ticker CDT
CIK 0001896212
other material
confidence high
sentiment neutral
materiality 0.60
Conduit Pharma stockholders approve reverse stock split up to 1-for-250 at special meeting
CDT Equity Inc.
- Proposal passed with 5,065,868 votes for, 496,473 against, 1,438 abstentions.
- Board may implement split at ratios from 1-for-2 to 1-for-100, aggregate not exceeding 1-for-250.
- The reverse stock split amendments to the certificate of incorporation have been authorized.
- Company's common stock trades under CDT on Nasdaq; warrants trade under CDTTW.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001641172-25-008854
- form_type
- 8-K
- ticker
- CDT
- cik
- 0001896212
- company_name
- CDT Equity Inc.
- filed_at
- 2025-05-06T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:50.407931+00:00
- generated_at
- 2026-05-22T14:20:52.067827+00:00
- sec_items
- ["5.07"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.6
- calibrated_materiality_score
- 0.6
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001641172-25-008854
- json_url
- https://secwatch.observer/filing/0001641172-25-008854.json
- markdown_url
- https://secwatch.observer/filing/0001641172-25-008854.md
- text_url
- https://secwatch.observer/filing/0001641172-25-008854.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1896212/000164117225008854/0001641172-25-008854-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1896212/000164117225008854/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
CRM
Salesforce shareholders approve 34M share equity plan increase, extend term to 2036, all directors re-elected
Salesforce, Inc.
June 1, 2026, 4:43 PM ET
other_material
Items 5.07, 5.02, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
SIRI
Sirius XM shareholders approve 7.2M share increase in 2024 equity plan, elect directors
SIRIUS XM HOLDINGS INC.
June 1, 2026, 4:28 PM ET
other_material
Items 5.02, 5.07, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
ESPR
Esperion shareholders approve 7M-share increase to 2022 equity incentive plan
Esperion Therapeutics, Inc.
June 1, 2026, 4:22 PM ET
other_material
Items 5.02, 5.07, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
DCOM
Dime Commercial Bancshares name change effective; three executives amend employment agreements
Dime Community Bancshares, Inc. /NY/
June 1, 2026, 4:02 PM ET
other_material
Items 5.02, 5.03, 5.07, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
AIRJ
AirJoule Technologies raises $15M in registered direct offering at $4.10/share
AirJoule Technologies Corp.
June 1, 2026, 8:34 AM ET
other_material
Items 1.01, 5.07, 7.01, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
RDAC
Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed
Rising Dragon Acquisition Corp.
June 1, 2026, 6:08 AM ET
other_material
Items 1.01, 5.03, 5.07, 8.01, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
BRTX
BRTX shareholders approve 20x increase in authorized shares; CEO/CFO sign 3-year employment agreements
BioRestorative Therapies, Inc.
May 29, 2026, 5:07 PM ET
other_material
Items 5.02, 5.07, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
TNYA
Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors
Tenaya Therapeutics, Inc.
May 29, 2026, 5:04 PM ET
other_material
Items 5.02, 5.07, 9.01
same SEC item: 5.07
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.